Audit-Ready
Risk Management for Complex Clinical Trials

Already Completed for You.

Implement consistent, traceable risk management across your clinical trials with a pre-filled Excel Risk Log,
using a
Phase I clinical trial in Oncology with an ATMP.
This is built for real-world Clinical Operations.

👉 Get the Pre-Filled Risk Log System Now
Do you recognise this?
  • Your Risk Management SOP exists, but implementation differs across clinical trials
  • Risk logs are incomplete, inconsistent, or not maintained actively
  • Teams assess risks differently without a shared structure
  • Critical risks are identified late instead of proactively
  • Inspection readiness relies on manual effort and reconstruction

This is not a knowledge gap.
It is a lack of a structured, operational risk management system. Because:
  • SOPs define expectations
  • But they do not ensure consistent execution


What if you could…
  • Apply risk management consistently across all clinical trials
  • Use a pre-defined risk assessment as a reference model
  • Ensure traceable and inspection-ready documentation
  • Align Clinical Operations, QA, and project teams
  • Strengthen your sponsor oversight approach


Risk Management in Clinical Trials
Pre-Filled Excel Risk Log (Phase I Oncology, ATMP)
A professionally structured and pre-filled system, designed to translate your SOP into real, operational execution.
  • User Group

    • Clinical Project Managers
    • Clinical Operations Leads
    • Quality Assurance Managers
  • Format

    Excel Word


  • Content

    ✔ A fully structured Excel Risk Log
    ✔ A pre-filled risk assessment for a Phase I in Oncology (basket design) with ATMP
    ✔ A clear framework for:
    • Risk identification
    • Risk evaluation
    • Risk mitigation
    • Risk tracking
    ✔ A reference model for sponsor oversight and decision-making
    ✔ Immediate usability (no setup required)

  • Benefits

    • Consistent risk management across clinical trials
    • Inspection-ready documentation with clear traceability
    • Reduced uncertainty in risk evaluation and mitigation
    • Improved cross-functional alignment
    • Faster implementation of your SOP in practice
This is not a generic template. Most templates provide structure.
This provides expert judgement and application.
You receive:
  • A pre-defined risk assessment for a complex clinical trial scenario
  • A clear example of how risks should be structured and documented
  • A system aligned with real clinical operations and regulatory expectations


We already have a Risk Management SOP.
Exactly. This risk log ensures your SOP is consistently applied in practice, not just documented.
________________________________________
Our team already manages risks.
Often, standardization across clinical trials is missing. This introduces a shared structure across clinical trials and teams.
________________________________________
We don’t have time to implement something new.
This is not additional work. It replaces fragmented approaches with a single, structured system.
________________________________________
Will this work for our clinical trial?
The structure is adaptable, while maintaining consistency, providing a reliable framework across different clinical trial types.

Developing a comparable structured risk assessment typically requires:
  • Significant internal alignment
  • Senior expertise
  • External consulting support


You receive

✔ Pre-filled expert-level risk assessment
✔ Operational risk management system
✔ Immediate application in your clinical trials

Ready to implement structured, audit-ready risk management?

How quickly can we implement this?

Immediately. The template is ready for direct use in ongoing clinical trials.

Is this suitable for GCP inspections?

The structure supports clear, traceable documentation, which is essential for inspections.

Can we adapt the template?

Yes. The structure is standardized (based on Transcelerate RACT) but flexible for your needs.

Is this applicable beyond a Phase I in Oncology?

Yes. The example provides a reference model, which can be adapted to other clinical trial types.
Created with